JENNALEE OLSEN: Open Payments
NPI 1629590765 · PLANKINTON, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$605 in 36 payments from 11 companies in 2025. Trend: 2023 $468 · 2024 $617 · 2025 $605
Food & beverage: $605
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $329 |
| PFIZER INC. | 3 | $53 |
| Novartis Pharmaceuticals Corporation | 2 | $39 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $38 |
| Lilly USA, LLC | 2 | $37 |
| Astellas Pharma US Inc | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
| Exact Sciences Corporation | 1 | $17 |
| Novo Nordisk Inc | 1 | $15 |
Products named: QULIPTA, VRAYLAR, NURTEC ODT, LEQVIO, CAPLYTA, Veozah, UBRELVY, MOUNJARO.
Industry payments across SD — which companies pay providers there.
